CDP3194

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	34

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

trials per page:

Showing 1 to 10 of 34 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-020859-30-IT (EUCTR)	23/06/2012	06/03/2012	Open-label study of long-term Epratuzumab treatment in subjects withSystemic Lupus Erythematosus (SL ...	A phase 3, multicenter, open-label, extension study to asssess the safety and tolerability of Epratu ...	Systemic lupus erythematosus MedDRA version: 14.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Epratuzumab Product Code: CDP3194 INN or Proposed INN: EPRATUZUMAB Other descriptive name ...	UCB Inc.	NULL	Not Recruiting			Female: yes Male: yes	1400	Phase 3	United States;Estonia;Taiwan;Hong Kong;Spain;Ukraine;Lithuania;Russian Federation;Israel;United King ...
2	EUCTR2010-020859-30-EE (EUCTR)	15/06/2012	04/06/2012	Open-label study of long-term Epratuzumab treatment in subjects with Systemic Lupus Erythematosus (S ...	A phase 3, multicenter, open-label, extension study to assess the safety and tolerability of Epratuz ...	Systemic Lupus Erythematosus MedDRA version: 18.0;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Epratuzumab Product Code: CDP3194 INN or Proposed INN: Epratuzumab	UCB Inc.	NULL	Not Recruiting			Female: yes Male: yes	1250	Phase 3	United States;Taiwan;Estonia;Hong Kong;Spain;Ukraine;Israel;Russian Federation;Italy;France;Australi ...
3	EUCTR2010-018563-41-EE (EUCTR)	09/04/2012	09/03/2012	Study of Epratuzumab versus Placebo in subjects with moderate to severe general Systemic Lupus Eryth ...	A phase 3, randomized, double-blind, placebo-controlled, multicenter study of the efficacy and safet ...	Systemic Lupus Erythmatosus MedDRA version: 17.0;Level: PT;Classification code 10042945;Term: System ...	Product Name: Epratuzumab Product Code: CDP3194 INN or Proposed INN: Epratuzumab	UCB Inc.	NULL	Not Recruiting			Female: yes Male: yes	780	Phase 3	Estonia;Taiwan;Spain;Lithuania;Israel;Russian Federation;Italy;United Kingdom;India;Czech Republic;M ...
4	EUCTR2010-018563-41-LT (EUCTR)	14/03/2012	14/02/2012	Study of Epratuzumab versus Placebo in subjects with moderate to severe general Systemic Lupus Eryth ...	A phase 3, randomized, double-blind, placebo-controlled, multicenter study of the efficacy and safet ...	Systemic Lupus Erythmatosus MedDRA version: 17.0;Level: PT;Classification code 10042945;Term: System ...	Product Name: Epratuzumab Product Code: CDP3194 INN or Proposed INN: Epratuzumab	UCB Inc.	NULL	Not Recruiting			Female: yes Male: yes	780	Phase 3	Estonia;Taiwan;Spain;Lithuania;Israel;Russian Federation;Italy;United Kingdom;India;Czech Republic;M ...
5	EUCTR2010-020859-30-BG (EUCTR)	18/11/2011	18/07/2011	Open-label study of long-term Epratuzumab treatment in subjects with Systemic Lupus Erythematosus (S ...	A phase 3, multicenter, open-label, extension study to assess the safety and tolerability of Epratuz ...	Systemic Lupus Erythematosus MedDRA version: 18.0;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Epratuzumab Product Code: CDP3194 INN or Proposed INN: Epratuzumab	UCB Inc.	NULL	Not Recruiting			Female: yes Male: yes	1250	Phase 3	United States;Estonia;Taiwan;Hong Kong;Spain;Ukraine;Russian Federation;Israel;Italy;France;Australi ...
6	EUCTR2010-020859-30-LT (EUCTR)	10/10/2011	11/08/2011	Open-label study of long-term Epratuzumab treatment in subjects with Systemic Lupus Erythematosus (S ...	A phase 3, multicenter, open-label, extension study to assess the safety and tolerability of Epratuz ...	Systemic Lupus Erythematosus MedDRA version: 18.0;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Epratuzumab Product Code: CDP3194 INN or Proposed INN: Epratuzumab	UCB Inc.	NULL	Not Recruiting			Female: yes Male: yes	1250	Phase 3	United States;Taiwan;Estonia;Hong Kong;Spain;Ukraine;Israel;Russian Federation;Italy;France;Australi ...
7	EUCTR2010-018565-26-IT (EUCTR)	15/09/2011	05/01/2012	Study of Epratuzumab versus Placebo in subjects with moderate to severe general Systemic Lupus Eryth ...	A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE EFFICACY AND SAFET ...	Systemic Lupus Erythmatosus MedDRA version: 14.1;Level: PT;Classification code 10042945;Term: System ...	Product Name: Epratuzumab Product Code: CDP3194 INN or Proposed INN: EPRATUZUMAB	UCB Inc.	NULL	Not Recruiting			Female: yes Male: yes	780	Phase 3	Hungary;Mexico;Canada;Spain;Brazil;Ukraine;South Africa;Russian Federation;Germany;United Kingdom;It ...
8	EUCTR2010-018563-41-BG (EUCTR)	02/09/2011	25/07/2011	Study of Epratuzumab versus Placebo in subjects with moderate to severe general Systemic Lupus Eryth ...	A phase 3, randomized, double-blind, placebo-controlled, multicenter study of the efficacy and safet ...	Systemic Lupus Erythmatosus MedDRA version: 14.1;Level: PT;Classification code 10042945;Term: System ...	Product Name: Epratuzumab Product Code: CDP3194 INN or Proposed INN: Epratuzumab	UCB Inc.	NULL	Not Recruiting			Female: yes Male: yes	780	Phase 3	Estonia;Taiwan;Spain;Lithuania;Russian Federation;Israel;Italy;United Kingdom;India;Czech Republic;M ...
9	EUCTR2010-020859-30-DE (EUCTR)	31/08/2011	24/01/2011	Open-label study of long-term Epratuzumab treatment in subjects with Systemic Lupus Erythematosus (S ...	A phase 3, multicenter, open-label, extension study to assess the safety and tolerability of Epratuz ...	Systemic Lupus Erythematosus MedDRA version: 14.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Epratuzumab Product Code: CDP3194 INN or Proposed INN: Epratuzumab	UCB Inc.	NULL	Not Recruiting			Female: yes Male: yes	1400	Phase 3	United States;Estonia;Taiwan;Hong Kong;Spain;Ukraine;Lithuania;Russian Federation;Israel;Italy;Unite ...
10	EUCTR2010-018563-41-IT (EUCTR)	23/06/2011	20/03/2012	Study of Epratuzumab versus Placebo in subjects with moderate to severe general Systemic Lupus Eryth ...	A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE EFFICACY AND SAFET ...	Systemic Lupus Erythmatosus MedDRA version: 14.1;Level: PT;Classification code 10042945;Term: System ...	Product Name: Epratuzumab Product Code: CDP3194 INN or Proposed INN: EPRATUZUMAB	UCB Inc.	NULL	Not Recruiting			Female: yes Male: yes	780	Phase 3	Estonia;Taiwan;Spain;Lithuania;Russian Federation;Israel;United Kingdom;Italy;India;Czech Republic;M ...

First Previous1 2 3 4Next Last